In December, 2019, a new coronavirus named 2019-nCoV causing severe acute respiratory disease has emerged in the region of Wuhan, China [1, 2]. The National Health Commission of People's Republic of China named pneumonia infected with 2019-nCoV as Novel Coronavirus Pneumonia (NCP).Evidence have pointing to the person-to-person transmission [3–5]. As of February 8, 2020, China has reported 34 673 confirmed and more than 27 657 suspected cases of NCP across 34 Chinese provinces or municipalities, with 106 fatalities. Most of the studies focused on the epidemic situation in Wuhan, but few on provinces outside Wuhan. Shaanxi is located in the northwest of Hubei Province and adjacent to it, with a population of 38.64 million. Since the first case of NCP was confirmed in Shannxi by on January 23, 2020, 195 cases have been confirmed, but there is no relevant epidemiological study. In order to better understand the epidemic law of new coronavirus in Shaanxi Province, and provide the basis for the future development of control measures.This article aims to report the epidemiological outcomes of 195 confirmed case infected with 2019-nCoV in Shaanxi, and to compare the clinical features between patients with or without a history of exposure in Wuhan.
The patients confirmed with NCP in Shaanxi Province are mainly have the history of Wuhan contact, There are characteristics of family aggregation and concealment.